Table 1 Patient characteristics
Training group (N = 248 cases) | Validation group (N = 99 cases) | |||||
|---|---|---|---|---|---|---|
Factors | NAAT | AAT | P | NAAT | AAT | P |
Age (%) | ||||||
46-68ys | 72 (55.8) | 57 (44.2) | 0.117 | 44 (75.9) | 14 (24.1) | 0.067 |
68-88ys | 78 (65.5) | 41 (34.5) | 24 (58.5) | 17 (41.5) | ||
T stage (%) | ||||||
1~2 | 36 (56.3) | 28 (43.7) | 0.789 | 21 (67.7) | 10 (32.3) | 0.933 |
3~4 | 114 (62.0) | 70 (38.0) | 45 (69.2) | 20 (30.8) | ||
N stage (%) | ||||||
0 | 92 (64.3) | 51 (35.7) | 0.148 | 40 (65.6) | 21 (34.4) | 0.375 |
1 | 58 (55.2) | 47 (44.8) | 26 (74.3) | 9 (25.7) | ||
M stage (%) | ||||||
0 | 90 (60.4) | 59 (39.6) | 0.974 | 48 (69.6) | 21 (30.4) | 0.775 |
1 | 60 (60.6) | 39 (39.4) | 20 (66.7) | 10 (33.3) | ||
Clinical stage (%) | ||||||
I~II | 23 (54.8) | 19 (45.2) | 0.753 | 18 (66.7) | 9 (33.3) | 0.880 |
III~IV | 127 (61.7) | 79 (38.3) | 50 (69.4) | 22 (30.6) | ||
GS group (%) | ||||||
6~7 | 66 (64.7) | 36 (35.3) | 0.256 | 25 (80.6) | 6 (19.4) | 0.074 |
8~10 | 84 (57.5) | 62 (42.5) | 40 (62.5) | 24 (37.5) | ||
TPSA before treatment (%) | ||||||
< 20 ng/mL | 22 (59.5) | 15 (40.5) | 0.890 | 40 (62.5) | 24 (37.5) | 0.226 |
≥ 20 ng/mL | 128 (60.7) | 83 (39.3) | 19 (76.0) | 6 (24.0) | ||
TPSA before RT (%)· | ||||||
< 20 ng/mL | 119 (60.1) | 79 (39.9) | 0.806 | 61 (67.0) | 30 (33.0) | 0.407 |
≥ 20 ng/mL | 31 (62.0) | 19 (28.0) | 5 (83.3) | 1 (16.7) | ||
RT type (%) | ||||||
IMRT/VMAT | 23 (67.6) | 11 (32.4) | 0.358 | 5 (50.0) | 5 (50.0) | 0.179 |
IMRT/VMAT-IGRT | 127 (59.3) | 87 (40.7) | 63 (70.8) | 26 (29.2) | ||
RT modality (%) | ||||||
Conventional fraction | 126 (62.1) | 77 (37.9) | 0.278 | 46 (66.7) | 23 (33.3) | 0.511 |
Hypo-fraction | 24 (53.3) | 21 (46.7) | 22 (73.3) | 8 (26.7) | ||
Surgery (%) | ||||||
No | 94 (61.4) | 59 (38.6) | 0.697 | 31 (62.0) | 19 (38.0) | 0.483 |
Yes | 56 (58.9) | 39 (41.1) | 33 (68.8) | 15 (31.3) | ||
Hormonal treatment duration (%) | ||||||
< 2 years | 23 (54.8) | 19 (45.2) | 0.405 | 17 (63.0) | 10 (37.0) | 0.730 |
≥ 2 years | 127 (61.7) | 79 (38.3) | 48 (66.7) | 24 (33.3) | ||
Hemorrhoid (%) | ||||||
NO | 95 (87.2) | 14 (12.8) | < 0.001 | 39 (83.0) | 8 (17.0) | 0.004 |
Yes | 55 (39.6) | 84 (60.4) | 29 (55.8) | 23 (44.2) | ||